Roger L. Novack

Randomized Trial of Treat and Extend Ranibizumab With and Without Navigated Laser Versus Monthly Dosing for Diabetic Macular Edema: TREX-DME 2-Year Outcomes

John F. Payne, Charles C. Wykoff, W. Lloyd Clark, Bonnie Bruce et autres

us (code pays fourni par la source)

Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration

Jeannette J. Yu, Elvira Agrón, Traci E. Clemons, Amitha Domalpally et autres

us (code pays fourni par la source)

Progression of Geographic Atrophy in Age-related Macular Degeneration

Tiarnán D L Keenan, Elvira Agrón, Amitha Domalpally, Traci E. Clemons et autres

us (code pays fourni par la source)

Retinopathy Regression with Treat and Extend Ranibizumab for Diabetic Macular Edema

John F. Payne, W. Lloyd Clark, Bonnie Bruce, Charles C. Wykoff et autres

us (code pays fourni par la source)

Emixustat Hydrochloride for Geographic Atrophy Secondary to Age-Related Macular Degeneration

Philip J. Rosenfeld, Pravin U. Dugel, Frank Gerhard Holz, Jeffrey S. Heier et autres

Purpose To determine whether emixustat hydrochloride (emixustat) reduces the rate of enlargement of geographic atrophy (GA) compared with placebo in subjects with age-related macular degeneration (AMD) and to evaluate the safety and tolerability of emixustat over 24 months of treatment. Design Multicenter, …

us, de (code pays fourni par la source)

Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema

Lee M. Jampol, Adam R. Glassman, Danni Liu, Lloyd Paul Aiello et autres

us (code pays fourni par la source)

Macula Society Collaborative Retrospective Study of Ocriplasmin for Symptomatic Vitreomacular Adhesion

Jennifer I. Lim, Adam R. Glassman, Lloyd Paul Aiello, Usha Chakravarthy et autres

us, gb (code pays fourni par la source)

PHASE II, RANDOMIZED, PLACEBO-CONTROLLED, 90-DAY STUDY OF EMIXUSTAT HYDROCHLORIDE IN GEOGRAPHIC ATROPHY ASSOCIATED WITH DRY AGE-RELATED MACULAR DEGENERATION

Pravin U. Dugel, Roger L. Novack, Karl G. Csaky, Preston P. Richmond et autres

In Brief Purpose: This study assessed the safety, tolerability, and pharmacodynamics of emixustat hydrochloride (ACU-4429), a novel visual cycle modulator, in subjects with geographic atrophy associated with dry age-related macular degeneration. Methods: Subjects were randomly assigned to oral emixustat (2, 5, 7, …

us (code pays fourni par la source)

Efficacy Comparison of Intravenous and Subcutaneous Recombinant Human Erythropoietin Administration in Hemodialysis Patients

J. Bömmer, Heidi Barth, M. Zeier, A Mandelbaum et autres

de (code pays fourni par la source)

Safety of Intravitreal Ocriplasmin for Focal Vitreomacular Adhesion in Patients with Exudative Age-Related Macular Degeneration

Roger L. Novack, Giovanni Staurenghi, Aniz Girach, Nirodhini Narendran et autres

us, it, gb (code pays fourni par la source)

Occlusion Caused by Cosmetic Facial Filler Injection—Reply

Michelle V. Carle, Richard H. Roe, Roger L. Novack

us (code pays fourni par la source)

Cosmetic Facial Fillers and Severe Vision Loss

Michelle V. Carle, Richard H. Roe, Roger L. Novack, David S. Boyer

IMPORTANCE: Dermal injection of cosmetic fillers can lead to irreversible blindness when injected in the forehead, and this possible adverse effect is not typically mentioned to patients. OBSERVATIONS: Vision loss from central retinal artery occlusion occurring, after cosmetic facial enhancement, was irreversible …

us (code pays fourni par la source)